Pipeline, aneurysms and the FDA
- 1Department of NeuroInterventional Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA
- 2Department of Interventional Neuroradiology, Massachusetts General Hospital, Boston, Massachusetts, USA
- 3Department of Endovasular Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA
- Correspondence to Dr Joshua A Hirsch, Department of NeuroInterventional Radiology, Massachusetts General Hospital, 55 Fruit Street, Gray 241B, Boston, MA 02114, USA; hirsch{at}snisonline.org
- Accepted 29 February 2012
- Published Online First 22 March 2012
Keywords:
We commend Brinjikji et al on their recent article estimating the proportion of intracranial aneurysms likely to be amenable to treatment with the pipeline embolization device (PED).1 Based on aneurysm and parent artery morphology, 47% of their consecutive sample of 200 aneurysms could theoretically be treated by the PED.
We believe the paper might …








